International Strategic Healthcare Communications. For further information [email protected]
London, England
Joined October 2017
- Tweets3.5K
- Following1.4K
- Followers490
- Likes4.5K
OptimumComms retweeted
📣Listen to our CEO Roman Thomas in the #LungCancerAwarenessMonth episode of the #OptimumPerspectives Podcast as he discusses the breakthroughs in #lungcancer treatments and @DISCOPharma to develop its #surfaceome mapping platform.
@health_journo @OptimumComms
OptimumComms retweeted
Excited to announce Gudrun Vogtentanz, CSO at @AMSilkG, as a featured speaker at @RethinkMaterial Summit on May 14, 2024, 17:15 in London! Join us to explore the bioeconomy and #AMSilk's groundbreaking spider silk-based materials. #RethinkingMaterials
OptimumComms retweeted
We are delighted to announce our $40m investment into D3 Bio, to support the development of it’s differentiated pipeline in oncology.
medicxi.com/news/medicxi-ann…
OptimumComms retweeted
We are excited to have received Clinical Trial Authorisation from the European Medicines Agency for our first-in-class Endocannabinoid System (ECS) modulator SYT-510
Learn more:synendos.com/post/january-20…
#EndocannabionoidSystem #CentralNervousSystem #CTA #EMA #SERI #neuropsychiatry
OptimumComms retweeted
@Biocomposites1 is pleased to announce the opening of its new sales and distribution office, and incorporation of #Biocomposites SRL, in Italy to support the sale of our #STIMULAN, #NanoBone, #genex and #SYNICEM Spacer products. Read more: biocomposites.com/news/bioco…
OptimumComms retweeted
Introducing @DISCOPharma!
The #surfaceome company.
DISCO's mission is to improve treatment options for patients living with cancer by unleashing the full potential of targeted cancer therapies.
Find out more: bit.ly/4aSbTkp
#drugdiscovery #biotech
OptimumComms retweeted
2023 was a year of notable milestones for the Novo Holdings Seed Investments team. >$460m raised by our portfolio companies and we launched SeedLab.
You can read the annual review here:
#lifescienceinvestments #venturecapital #venturecreation #biotech
novoholdings.dk/news/2023-no…
OptimumComms retweeted
Welcome Robert Coleman - our new CEO!
Robert's proven ability to navigate from early-stage innovation to clinical advancement will undoubtedly play a pivotal role in realizing the full potential of @Hervolutiontx 's pioneering #immunotherapies.
Read more: hervolutiontx.com/2023/12/19…
OptimumComms retweeted
@versameb is delighted to announce FDA clearance of IND Application for its lead candidate VMB-100 in the treatment of stress urinary incontinence (SUI).
Read more here: versameb.com/versameb-announ…
#FDA #IND #urology #SUI #incontinence #mRNA #clinicaldevelopment
OptimumComms retweeted
@Ariceum_tx has won the Deal of the Year (<€500M) #Award at the @LSXLeaders European Lifestars Awards!
Thank you to #LSX for nominating us and a huge thank you to the #Ariceum team for their hard work, dedication and passion. Congratulations to the other winners and finalists!
OptimumComms retweeted
Open for business! Thanks to @EdMiliband for officially unveiling our newly extended 3PL warehouse in Doncaster on Friday!
Read more: mawdsleys.co.uk/news/we-unve…
#pharmaceutical #3pl #warehousing #solarenergy #environmentalimpact
OptimumComms retweeted
#POLB @PoolbegPharma - Featured in a @EPM_Magazine
- Were featured in "Could #AI save us from the next pandemic?", which highlights the advancements in technology & healthcare is aiding the future for pandemic prevention."
Read article here: shorturl.at/gxFQ5
OptimumComms retweeted
We were featured in a @EPM_Magazine on "Could #AI save us from the next pandemic?", which highlights the advancements in technology & healthcare is aiding the future for #pandemic prevention.
Read article here:
pharmaceuticalmanufacturer.m…
#POLB $POLBF #ArtificialInteligence #health
OptimumComms retweeted
Exciting news from @IOBiotech! Today we announced promising preliminary data from the Phase 2 basket trial of IO102-IO103 in combination with KEYTRUDA® at the #ESMO2023 Congress in Madrid. Read more: investors.iobiotech.com/news… #IOBiotech #CancerResearch #Immunotherapy
OptimumComms retweeted
Exciting news from @IOBiotech! We're thrilled to announce our participation in @sitcancer 's 38th Annual Meeting (#SITC2023) in San Diego, Nov 1-5, 2023. Join us as we present 3 posters highlighting our advancements in #cancerimmunotherapy. More info: investors.iobiotech.com/news…
OptimumComms retweeted
@HERVOLUTION is honoured to welcome Professor Robert Langer, co-founder of Moderna and MIT Professor, as Chair of its Scientific Advisory Board.
Read more here: hervolutiontx.com/2023/09/13…
#HERVs #immunotherapy
OptimumComms retweeted
Today #Ariceum shares the exciting news that it has dosed its #firstpatient with #satoreotide, its first-in-class #radiopharmaceutical drug targeting extensive stage small cell lung cancer!
Read the press release, here: bit.ly/3ENsuah
#cancer #SCLC
OptimumComms retweeted
Come and meet the @Ariceum_Tx team at the 10th International Symposium on the Physical, Molecular, Cellular and Medical Aspects of Auger Electron Processes in Montpellier on 6-8 September.
We are excited to join the symposium and look forward to networking with other attendees!
OptimumComms retweeted
Excited to publish animal model data on our first #clinical #drug candidate, RJx-01, showing significant benefits in treating #sarcopenia, the age-related loss of muscle mass and strength. Read our #paper: insight.jci.org/articles/vie… and full #pressrelease: ow.ly/woXR50PvuLI
